More than 31 million Americans are living with eczema/ atopic dermatitis (AD), a chronic inflammatory skin condition that extends far beyond visible symptoms to disrupt sleep, mental health, and daily ...

DelveInsight’s “Atopic Dermatitis Pipeline Insight 2025” report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in the Atopic Dermatitis pipeline landscape. It covers the ...

Experts discuss the recent FDA approval of topical JAK inhibitors for children 2 years or older as a promising advancement in pediatric atopic dermatitis treatment, highlighting their efficacy, their ...

Experts discuss the importance of balancing effective symptom control with quality of life in managing chronic pediatric atopic dermatitis, emphasizing personalized treatment plans that address both ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. Sure is a lot longer list than it used to ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Over the past ...

When you have atopic dermatitis, a form of eczema, it can be easy to dismiss symptoms like dry, itchy skin as normal for you. But even if you’re able to live with these symptoms, doing so can create a ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

Maybe your child has been on a specific treatment for atopic dermatitis (also called eczema) for months or even years, but now flare-ups seem to be happening more often and with greater intensity. Or ...

This article was originally published in French on Medscape. PARIS — The 17th Congrès Francophone d'allergologie (CFA), a congress of French-speaking allergists, took place April 19-April 22 at the ...

Please provide your email address to receive an email when new articles are posted on . Tralokinumab significantly improved atopic dermatitis in adolescents, according to phase 3 trial results ...